Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multimodality approach to localized rectal cancer.
Cervantes A, Chirivella I, Rodriguez-Braun E, Campos S, Navarro S, García Granero E. Cervantes A, et al. Ann Oncol. 2006 Sep;17 Suppl 10:x129-34. doi: 10.1093/annonc/mdl250. Ann Oncol. 2006. PMID: 17018713 Free article. Review. No abstract available.
Integrative decisions in rectal cancer.
Cervantes A, Rodríguez-Braun E, Navarro S, Hernández A, Campos S, García-Granero E. Cervantes A, et al. Ann Oncol. 2007 Jul;18 Suppl 9:ix127-31. doi: 10.1093/annonc/mdm307. Ann Oncol. 2007. PMID: 17631565 Free article. Review. No abstract available.
Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.
Martín-Martorell P, Roselló S, Rodríguez-Braun E, Chirivella I, Bosch A, Cervantes A. Martín-Martorell P, et al. Among authors: cervantes a. Br J Cancer. 2008 Aug 5;99(3):455-8. doi: 10.1038/sj.bjc.6604530. Br J Cancer. 2008. PMID: 18665167 Free PMC article. Clinical Trial.
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study.
Tabernero J, Ciardiello F, Rivera F, Rodriguez-Braun E, Ramos FJ, Martinelli E, Vega-Villegas ME, Roselló S, Liebscher S, Kisker O, Macarulla T, Baselga J, Cervantes A. Tabernero J, et al. Among authors: cervantes a. Ann Oncol. 2010 Jul;21(7):1537-1545. doi: 10.1093/annonc/mdp549. Epub 2009 Nov 25. Ann Oncol. 2010. PMID: 19940007 Free article. Clinical Trial.
Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines.
Pérez Fidalgo JA, García Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F; ESMO Guidelines Working Group. Pérez Fidalgo JA, et al. Among authors: cervantes a. Ann Oncol. 2012 Oct;23 Suppl 7:vii167-73. doi: 10.1093/annonc/mds294. Ann Oncol. 2012. PMID: 22997449 Free article. No abstract available.
Current questions for the treatment of advanced gastric cancer.
Cervantes A, Roda D, Tarazona N, Roselló S, Pérez-Fidalgo JA. Cervantes A, et al. Cancer Treat Rev. 2013 Feb;39(1):60-7. doi: 10.1016/j.ctrv.2012.09.007. Epub 2012 Oct 25. Cancer Treat Rev. 2013. PMID: 23102520 Review.
630 results